Literature DB >> 6771804

The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.

P B Silverman, B T Ho.   

Abstract

Rats were trained in a two-lever operant procedure to discriminate either 1.0 mg/kg (+)amphetamine or 1.5 mg/kg DOM from saline. Rats trained to discriminate DOM from saline showed generalization with the DOM training condition when tested with mescaline or 2,5-dimethoxy-4-ethylamphetamine (DOET), but not when tested with (+)amphetamine or methylphenidate. Both isomers of DOM generalized with racemic training compound, the (-)isomer being more potent. The DOM stimulus was completely blocked by the serotonin (5-HT) antagonists cinanserin and methysergide, but not by the peripheral 5-HT antagonist xylamidine nor the dopamine antagonist haloperidol. Rats trained to discriminate (+)amphetamine from saline generalized with the amphetamine training condition when tested with methylphenidate but not when tested with mescaline, DOET, racemic DOM, or either isomer of DOM. The amphetamine stimulus was blocked by pretreatment with haloperidol but not by cinanserin, methysergide, or xylamidine. The results show that, despite their structural similarity, amphetamine and DOM induce pharmacologically distinct stimuli.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771804     DOI: 10.1007/bf00428105

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD).

Authors:  I D Hirschhorn; J A Rosecrans
Journal:  Pharmacol Biochem Behav       Date:  1974-05       Impact factor: 3.533

2.  An hallucinogenic amphetamine analog (DOM) in man.

Authors:  L E Hollister; M F Macnicol; H K Gillespie
Journal:  Psychopharmacologia       Date:  1969

3.  Behavioural models of psychosis.

Authors:  J R Smythies; V S Johnston; R J Bradley
Journal:  Br J Psychiatry       Date:  1969-01       Impact factor: 9.319

4.  Blockade of the stimulus properties of mescaline by a serotonin antagonist.

Authors:  J C Winter
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-04

5.  Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.

Authors:  J C Winter
Journal:  J Pharmacol Exp Ther       Date:  1978-02       Impact factor: 4.030

6.  Effects of S-(+)- and R-(-)-3,4,dimethoxyphenylisopropylamines in the rat.

Authors:  C F Barfknecht; D E Nichols
Journal:  J Med Chem       Date:  1972-01       Impact factor: 7.446

7.  Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.

Authors:  J P Bennett; S H snyder
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

8.  Stereoselective effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) on schedule-controlled behavior.

Authors:  R A Harris; D Snell; H H Loh
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

9.  Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.

Authors:  H A Tilson; T G Baker; J H Chamberlain
Journal:  Psychopharmacologia       Date:  1975-11-21

10.  DOET (2,5-dimethoxy-4-ethylamphetamine), a new psychotropic drug. Effects of varying doses in man.

Authors:  S H Snyder; H Weingartner; L A Faillace
Journal:  Arch Gen Psychiatry       Date:  1971-01
View more
  11 in total

1.  Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.

Authors:  Erin S Calipari; Sara R Jones
Journal:  Neuropharmacology       Date:  2014-03-13       Impact factor: 5.250

2.  Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.

Authors:  J Koerner; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems.

Authors:  M A Nader; S M Hoffmann; J E Barrett
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 4.  Drug discrimination by humans compared to nonhumans: current status and future directions.

Authors:  J B Kamien; W K Bickel; J R Hughes; S T Higgins; B J Smith
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Discriminative stimulus properties of pizotifen maleate (BC105): a putative serotonin antagonist.

Authors:  D J Minnema; J S Hendry; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.

Authors:  Jun-Xu Li; Alison Unzeitig; Martin A Javors; Kenner C Rice; Wouter Koek; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2009-08-17       Impact factor: 4.030

7.  Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.

Authors:  J C Winter
Journal:  Psychopharmacology (Berl)       Date:  2008-11-01       Impact factor: 4.530

8.  Psilocybin-induced stimulus control in the rat.

Authors:  J C Winter; K C Rice; D J Amorosi; R A Rabin
Journal:  Pharmacol Biochem Behav       Date:  2007-06-22       Impact factor: 3.533

9.  The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.

Authors:  D Fiorella; P A Palumbo; R A Rabin; J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

10.  Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.

Authors:  Adam L Halberstadt; Muhammad Chatha; Adam K Klein; Jason Wallach; Simon D Brandt
Journal:  Neuropharmacology       Date:  2020-01-07       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.